miR-101-5p Acts as a Tumor Suppressor in HER2-Positive Breast Cancer Cells and Improves Targeted Therapy

PURPOSE: Human epidermal growth factor receptor 2 positive (HER2+) breast cancers responding poorly to targeted therapy need improved treatment options. miR-101-5p has shown tumor-suppressive properties in multiple cancer forms, and we assessed the effect and mechanism of action of this miRNA in HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Normann, Lisa Svartdal, Haugen, Mads Haugland, Aure, Miriam Ragle, Kristensen, Vessela N, Mælandsmo, Gunhild Mari, Sahlberg, Kristine Kleivi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898020/
https://www.ncbi.nlm.nih.gov/pubmed/35256859
http://dx.doi.org/10.2147/BCTT.S338404

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898020/
https://www.ncbi.nlm.nih.gov/pubmed/35256859
http://dx.doi.org/10.2147/BCTT.S338404

Ejemplares similares